Research Overview BPC-157 is a synthetic pentadecapeptide (Body Protection Compound) derived from a gastric protein sequence
However, if your research protocol explicitly calls for an IM injection, your needle requirements change completely
Practical Implementation for Research Applications For anti-aging and skin rejuvenation research protocols, implementation uses 1-2 mg daily subcutaneous injection with optional combination topical 0.5-1% GHK-Cu serum, running 8-12 week cycles with 4-6 week off periods, repeating cycles 2-3 times per year
Damage to any part of the spinal column, including discs and facet joints , can compress or irritate nearby nerves
Findings include: Accelerated wound closure rates in multiple animal models Enhanced re-epithelialization and granulation tissue formation Improved collagen deposition and organization in healing wounds Reduced scar formation and improved cosmetic outcomes GHK-Cu specifically demonstrated increases in skin thickness, elasticity, and firmness in controlled studies, while BPC-157 showed protective effects against various skin damage models